Vogenx

Manufacturing · North Carolina, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

3920 S Alston Ave, Durham, North Carolin...

Phone Number

(919) 659-5677

Revenue

-

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Vogenx

Vogenx, Inc. is a clinical-stage life science and drug development company headquartered in Durham, North Carolina. The company focuses on developing novel therapeutics for diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, gastroparesis, and obesity. Its lead compound is a first-in-class, oral, small molecule drug candidate (mizagliflozin) designed to inhibit postprandial glucose absorption and reduce excessive insulin and gastric inhibitory peptide secretion. Vogenx is dedicated to improving outcomes for patients suffering from serious metabolic and gastrointestinal conditions through innovative, science-driven treatment approaches.Explore more
Vogenx's Social MediaPopular SearchesVogenxVogenx IncMy SiteSIC Code 28,283NAICS Code 32,325Show more

Vogenx Org Chart

JG
United States flag for contact location.

Chief Executive Officer

PhoneEmail
SD
United States flag for contact location.

Chief Financial Officer & Member of The Board...

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Vogenx your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Vogenx

Compare insights from companies similar to Vogenx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Vogenx

1-10
Private
-
2021
<$5M
1-10
Private
$17M
2021
TH
Timothy HaysteadPresident & Founder
<$5M
11-50
Private
-
-
Samson Tom, President & Chief Executive Officer at Britecyte
Samson TomPresident & CEO
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Vogenx is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Vogenx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vogenx.

Vogenx Tech Stack

A closer look at the technologies used by Vogenx

Top Manufacturing Companies

Frequently Asked Questions Regarding Vogenx

What is Vogenx's official website?
Vogenx's official website is www.vogenx.com
What is Vogenx's SIC code?
Vogenx's SIC: 28,283
What is Vogenx's NAICS code?
Vogenx's NAICS: 32,325
How many employees does Vogenx have?
Vogenx has 1-10 employees
What industry does Vogenx belong to?
Vogenx is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Vogenx competition?
Vogenx top competitors include: Britecyte, EydisBio, Ablenio Biosciences, Garage 10
What technology does Vogenx use?
Some of the popular technologies that Vogenx uses are: WooCommerce, WordPress.org, PHP, Google Font API
Who is the CFO of Vogenx?
Vogenx's CFO is Steven Delmar
How do I contact Vogenx?
Vogenx contact info: Phone number: (919) 659-5677 Website: www.vogenx.com
What does Vogenx do?

Vogenx, Inc. is a clinical-stage life science and drug development company headquartered in Durham, North Carolina. The company focuses on developing novel therapeutics for diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, gastroparesis, and obesity. Its lead compound is a first-in-class, oral, small... molecule drug candidate (mizagliflozin) designed to inhibit postprandial glucose absorption and reduce excessive insulin and gastric inhibitory peptide secretion. Vogenx is dedicated to improving outcomes for patients suffering from serious metabolic and gastrointestinal conditions through innovative, science-driven treatment approaches.Read More

What are Vogenx social media links?
Vogenx Linkedin page
Is Vogenx a public company?
Vogenx is private company therefore does not currently have an official ticker symbol
See more information about Vogenx

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.